Broll R, Schauer V, Schimmelpenning H, Strik M, Woltmann A, Best R, Bruch H P, Duchrow M
Surgical Research, Medical University of Luebeck, Germany.
Dis Colon Rectum. 1997 Dec;40(12):1465-71. doi: 10.1007/BF02070713.
Whereas lymph node metastases in colorectal carcinoma are an important prognostic factor, the prognostic relevance of occult tumor cells in lymph nodes is not elucidated at present. Therefore, our study intended to assess the rate of patients with occult tumor cells in histopathologically negative lymph nodes. Furthermore, we tried to evaluate an eventual influence of these occult tumor cells on patients' prognoses.
For examination, we used paraffin blocks of lymph nodes, tumor-negative by conventional histopathology, from 49 patients with colorectal carcinoma (Stage I-III) after a curative (R0) tumor resection in 1987. After preparation of tissue blocks using the serial sectioning technique, the specimens were stained with the alkaline phosphatase, antialkaline phosphatase method and two monoclonal antibodies (AE1/AE3 and Ber-EP4).
In 13 of 49 patients (26.5 percent), we disclosed tumor cells, mostly located in subcapsular sinuses as single cells or in groups. There was a good correlation between the detection rate and N category, tumor stage, and grading. Moreover, 33 percent of patients in Stage I/II with occult tumor cells (N0+) developed a local relapse and/or distant metastases in contrast to 12 percent of patients without tumor cells (N0-). With a median follow-up of 84 months, we found no difference in disease-free survival between the tumor cell negative and positive groups in Stage I/II patients.
The results show that occult tumor cells might increase the risk for development of a local tumor relapse and/or distant metastases but do not influence patients' prognoses at all.
鉴于结直肠癌中的淋巴结转移是一个重要的预后因素,目前尚不清楚淋巴结中隐匿性肿瘤细胞的预后相关性。因此,我们的研究旨在评估组织病理学检查阴性的淋巴结中存在隐匿性肿瘤细胞的患者比例。此外,我们试图评估这些隐匿性肿瘤细胞对患者预后的最终影响。
为进行检查,我们使用了1987年接受根治性(R0)肿瘤切除的49例结直肠癌(I-III期)患者经传统组织病理学检查为肿瘤阴性的淋巴结石蜡块。使用连续切片技术制备组织块后,标本用碱性磷酸酶、抗碱性磷酸酶方法和两种单克隆抗体(AE1/AE3和Ber-EP4)进行染色。
在49例患者中的13例(26.5%)中,我们发现了肿瘤细胞,大多数位于被膜下窦,呈单个细胞或成簇存在。检出率与N分类、肿瘤分期和分级之间存在良好的相关性。此外,I/II期有隐匿性肿瘤细胞(N0+)的患者中有33%发生了局部复发和/或远处转移,而无肿瘤细胞(N0-)的患者中这一比例为12%。中位随访84个月后,我们发现I/II期患者中肿瘤细胞阴性和阳性组之间的无病生存率没有差异。
结果表明,隐匿性肿瘤细胞可能会增加局部肿瘤复发和/或远处转移的发生风险,但对患者的预后并无影响。